127 results on '"Kollmeier, M.A."'
Search Results
2. Pre-Brachytherapy Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Response as Predictor of Local Control in the Definitive Treatment of Cervical Cancer
3. FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)
4. Feasibility of Using a Single Planning MRI for Two-Insertion Intracavitary Brachytherapy for Cervical Cancer
5. Combined Brachytherapy and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Comparison of Toxicity Outcomes Using a High-Dose Rate (HDR) vs. Low-Dose Rate (LDR) Brachytherapy Boost
6. Superior Post-Treatment Biopsy Outcomes with High Dose SBRT Compared to High-Dose Conventionally Fractionated IMRT for Clinically Localized Prostate Cancer
7. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study
8. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer
9. Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiotherapy and Association of Metric Score With Dosimetric and Gastrointestinal Toxicity Outcomes
10. Minimum Bladder Reference Contour to Guide Bladder Filling for Prostate Radiotherapy
11. Sildenafil Citrate Does Not Impact Risk of Biochemical Recurrence in a Randomized Trial of Sexual Function Preservation with Prostate Cancer Radiation
12. Higher SBRT Dose Levels for Localized Prostate Cancer Are Associated with Improved Post-treatment Biopsy Outcomes
13. Effectiveness and Secondary Incontinence Rates after Urethroplasty for Severe Radiation-Induced Urethral Stenosis: A Systematic Review and Meta-Analysis
14. URINARY MORBIDITY AND INCONTINENCE FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE AFTER BRACHYTHERAPY
15. Predictors of Intra-Fraction Prostate Motion during Stereotactic Body Radiation Therapy (SBRT)
16. Underutilization of Adjuvant Radiation in Early Stage High Risk Endometrial Cancer
17. Clinical Outcomes of Combined Prostate-Directed and Metastasis-Directed Radiotherapy for Treatment of De Novo Oligometastatic Prostate Cancer
18. Predictors of Sexual Function Outcome after Stereotactic Body Radiotherapy for Localized Prostate Cancer
19. Utilization of Radiation Fractionation for Bone Metastases at the End of Life in the Era of SBRT: A Large Single Institution Longitudinal Experience
20. A Single-Arm Clinical Trial Investigating the Effectiveness of a Non-Hormonal Vaginal Moisturizer in Endometrial Cancer Survivors
21. Prostate Cancer and Benign Tissue Response to Hypofractionated SBRT Monitored by Multi-modality MRI over a 2 year Period
22. A Phase I Trial of Dose-Escalated Image-Guided, Intensity Modulated Radiation Therapy in Combination with Concurrent Gemcitabine Chemotherapy for Node-Negative, Muscle-Invasive Bladder Cancer (MIBC)
23. Are All High-Intermediate Risk Early Stage Endometrioid Carcinomas of the Uterus Created Equal?
24. A Phase II Trial of Low Dose Rate Brachytherapy Combined with Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiation Therapy for Clinically Localized, Intermediate Risk Prostate Cancer: A Preliminary Analysis
25. The First Prostate Specific Antigen Value after Androgen Deprivation Therapy Initiation and after Definitive Radiation Therapy Completion As a Biomarker For Disease Relapse and Mortality in Intermediate and High Risk Prostate Cancer
26. Multi-Institutional Phase 2 Trial of High-Dose Stereotactic Body Radiation Therapy with Temporary Hydrogel Spacer for Low- and Intermediate-Risk Prostate Cancer
27. Association of Delayed Adjuvant Therapy and Overall Survival in Early Stage Endometrial Cancer
28. 5-Year Outcomes of a Phase 1 Dose Escalation Study Using Stereotactic Body Radiosurgery for Patients with Clinically Localized Prostate Cancer
29. Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data
30. Changes in Multimodality MRI Characteristics Following SBRT in Prostate Cancer
31. Patterns of Lymph Node Failure After Dose-Escalated Radiation Therapy in Patients Who Did Not Undergo Pelvic Lymph Node Irradiation: Implications for Extended Pelvic Lymph Node Coverage
32. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer
33. Dosimetric Predictors of Sacral Insufficiency Fractures in Patients With Cervical and Endometrial Cancer Treated With Postoperative Intensity Modulated Radiation Treatment
34. Patterns of Relapse in Patients With Endometrial Cancer Treated With Postoperative Intensity Modulated Radiation Therapy (IMRT)
35. Deleterious Alterations in DNA Damage Response Genes Are Associated With Improved Outcome in Muscle-Invasive Bladder Cancer Patients Treated With Radiation-Based Bladder Preservation
36. Impact of Postoperative Intensity Modulated Radiation Therapy (IMRT) on the Rate of Bowel Obstruction in Gynecologic Malignancy
37. Extended Follow-up of Late Toxicity in a Large Cohort of Prostate Cancer Patients Treated With Definitive External Beam Radiation Therapy
38. A Redefined Risk Stratification System for Patients With Stage I-II Myometrial Invasive Endometrioid Adenocarcinoma
39. Correlation of Long-term Biochemical and Distant Metastases Outcome With Posttreatment Biopsy Results for Patients Treated With External Beam Radiation Therapy for Prostate Cancer
40. Comparison of Early-Stage Uterine Papillary Serous Carcinoma (UPSC) and Carcinosarcoma Treated With Adjuvant Carboplatin/Taxane Chemotherapy and Intravaginal Radiation Therapy (IVRT)
41. Long-term Impact of Androgen Deprivation Therapy on Cardiovascular Morbidity after Radiotherapy for Clinically Localized Prostate Cancer
42. Continuous Monitoring and Intra fraction Target Position Correction During Treatment Is Essential for Patients Undergoing SBRT Prostate Therapy With Tight Target Margins
43. Prostate-Specific Antigen Bounce After Dose-Escalated Radiation Therapy for Prostate Cancer is an Independent Predictor for Distant Metastasis, Cancer-Specific Survival, and Overall Survival
44. Image-Guided Intensity Modulated Radiation Therapy (IMRT) for Bladder Cancer: Toxicity and Early Outcomes
45. Patterns of Relapse in Stage I-II Uterine Papillary Serous Carcinoma Treated With Adjuvant Intravaginal Radiation (IVRT)
46. Quantifying the Risk of Recurrence and Death in Stage III (FIGO 2009) Endometrial Cancer
47. FDG PET Imaging in Cervical Cancer Patients Treated With Chemoradiation Therapy
48. Prostate-Specific Antigen (PSA) Doubling Time at Time of PSA Relapse Is an Independent Predictor for Distant Metastasis and Survival After External Beam Radiation Therapy
49. Use of Anticoagulants Predict Late Rectal Bleeding Following Definitive External Beam Radiation Therapy for Prostate Cancer
50. Second Cancer Risk Following Radiation Therapy for Seminoma: A Single Institution Retrospective Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.